Viridian Therapeutics, Inc.\DE short interest in 2022
In 2022, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 1.56% of shares outstanding on 14 Jan 2022 to 6.85% on 30 Dec 2022, a change of +5.29 percentage points. The year's high was 10.17% on 15 Jul 2022 and its low 1.56% on 14 Jan 2022, averaging 5.58% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.81 days on 29 Jul 2022. Full history: Viridian Therapeutics, Inc.\DE.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 1.56% (14 Jan 2022)
- End of year
- 6.85% (30 Dec 2022)
- Change
- +5.29 pp
- High
- 10.17% (15 Jul 2022)
- Low
- 1.56% (14 Jan 2022)
- Average
- 5.58%
- Highest days to cover
- 12.81 (29 Jul 2022)
- SEC filings marked
- 7
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 1.56% | 4.29 | |
| 31 Jan 2022 | 1.60% | 7.27 | |
| 15 Feb 2022 | 1.56% | 8.01 | |
| 28 Feb 2022 | 1.96% | 4.17 | |
| 15 Mar 2022 | 2.08% | 4.07 | results (8-K), 10-K filed |
| 31 Mar 2022 | 1.93% | 3.72 | |
| 14 Apr 2022 | 2.06% | 3.15 | |
| 29 Apr 2022 | 3.18% | 5.67 | |
| 13 May 2022 | 5.18% | 3.75 | results (8-K), 10-Q filed |
| 31 May 2022 | 5.76% | 6.03 | |
| 15 Jun 2022 | 6.74% | 5.67 | |
| 30 Jun 2022 | 9.07% | 3.27 | |
| 15 Jul 2022 | 10.17% | 10.72 | |
| 29 Jul 2022 | 10.10% | 12.81 | |
| 15 Aug 2022 | 8.97% | 1.74 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 5.00% | 1.07 | |
| 15 Sep 2022 | 6.69% | 3.33 | |
| 30 Sep 2022 | 7.46% | 4.04 | |
| 14 Oct 2022 | 7.83% | 6.41 | |
| 31 Oct 2022 | 7.93% | 5.72 | |
| 15 Nov 2022 | 7.02% | 5.82 | 10-Q filed |
| 30 Nov 2022 | 7.23% | 3.92 | |
| 15 Dec 2022 | 6.05% | 3.81 | |
| 30 Dec 2022 | 6.85% | 4.36 |
See also: Viridian Therapeutics, Inc.\DE's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.